Back
Theriva Biologics 10K Form
Sell
42
TOVX
Theriva Biologics
Last Price:
1.24
Seasonality Move:
98.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TOVX News And Ratings
See the #1 stock for the next 7 days that we like better than TOVX
TOVX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.61M |
|---|---|
| Cash Flow: | $-3.91M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.41 |
| Price / Book: | 0.14 |
Profitability
| EPS (TTM): | -33.18000 |
|---|---|
| Net Income (TTM): | $-26.69M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Theriva Biologics Earnings Forecast
Key Theriva Biologics Financial Ratios
- The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
- The Interest Expense is -0.26% of Operating Income.
- Per Share Earnings over the last 19 years have been positive in 12 years.
Theriva Biologics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TOVX |
| Website: | therivabio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TOVX Technical Analysis vs Fundamental Analysis
Sell
42
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a Sell
The current Theriva Biologics [TOVX] share price is $1.26. The Score for TOVX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.